A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas (Q41612110)

5 October 2017

A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas (English)

1 reference

5 October 2017

Victor D Martinez

6

0 references

Ralf Kittler

object named as

Ralf Kittler

12

0 references

Chao Xing

object named as

Chao Xing

11

0 references

author name string

Kelsie L Thu

1

1 reference

5 October 2017

Mahboubeh Papari-Zareei

2

1 reference

5 October 2017

Victor Stastny

3

1 reference

5 October 2017

Kai Song

4

1 reference

5 October 2017

Michael Peyton

5

1 reference

5 October 2017

Yu-An Zhang

7

1 reference

5 October 2017

Isabel B Castro

8

1 reference

5 October 2017

Marileila Varella-Garcia

9

1 reference

5 October 2017

Hanquan Liang

10

1 reference

5 October 2017

Sara Milchgrub

13

1 reference

5 October 2017

Diego H Castrillon

14

1 reference

5 October 2017

Heather L Davidson

15

1 reference

5 October 2017

C Patrick Reynolds

16

1 reference

5 October 2017

Wan L Lam

17

1 reference

5 October 2017

Jayanthi Lea

18

1 reference

5 October 2017

Adi F Gazdar

19

1 reference

5 October 2017

language of work or name

English

0 references

publication date

10 June 2016

1 reference

5 October 2017

1 reference

5 October 2017

8

1 reference

5 October 2017

50489-50499

1 reference

5 October 2017

31

1 reference

Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours

5 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

6 June 2018

Cancer statistics, 2015

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Reliable in vitro studies require appropriate ovarian cancer cell lines

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Low-grade serous tumors of ovary

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Cancer cell lines for drug discovery and development

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Malignant ascites in ovarian cancer and the role of targeted therapeutics

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Current status and evolution of preclinical drug development models of epithelial ovarian cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Mutational landscape and significance across 12 major cancer types

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Type-specific cell line models for type-specific ovarian cancer research

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Evaluating cell lines as tumour models by comparison of genomic profiles

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Personalizing oncology: perspectives and prospects

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The clinical relevance of cancer cell lines.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The UCSC Cancer Genomics Browser: update 2013.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The changing view of high-grade serous ovarian cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Rethinking ovarian cancer: recommendations for improving outcomes

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Integrated genomic analyses of ovarian carcinoma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

EpCAM in carcinogenesis: the good, the bad or the ugly

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Lung cancer cell lines as tools for biomedical discovery and research

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Ovarian cancer: the duplicity of CA125 measurement

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The biology of ovarian cancer: new opportunities for translation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Human leukemia and lymphoma cell lines as models and resources

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Spectral karyotyping detects chromosome damage in bronchial cells of smokers and patients with cancer

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

New tumor markers: CA125 and beyond.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

The genesis and evolution of high-grade serous ovarian cancer.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5584155

Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens

2 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28881577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28881577

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.9929

1 reference

5 October 2017

1 reference

5 October 2017

1 reference